CIK 0001808805 · Non-accelerated filer<br>Smaller reporting company
Nautilus Biotechnology, Inc.
Sign in to watch- Ticker
- NAUT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981541723
- Phone
- 206-333-2001
- Business address
- 2701 EASTLAKE AVE EAST, SEATTLE, WA, 98102
- Former names
- ARYA Sciences Acquisition Corp III
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | Mowry Anna CFO and Treasurer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2024-03-01 | Weld Gwen E Chief People Officer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2024-03-01 | Murphy Matthew B. General Counsel | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2024-03-01 | Sankar Subramanian Senior VP, Product Development | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2024-03-01 | Godwin Mary E. Senior VP, Operations | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2023-06-15 | PERCEPTIVE ADVISORS LLC Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2023-06-15 | ALTMAN MICHAEL SETH Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2023-06-15 | McIlwain Matthew S Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2023-06-15 | Posard Matthew L. Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2023-06-15 | Pande Vijay Satyanand Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2023-06-15 | Epperly Melissa B, Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2023-06-15 | NAZEM FARZAD Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2023-06-15 | Akinsanya Karen Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2023-02-27 | Patel Sujal M CEO, President, and Secretary | Grant or award · Stock Option (Right to Buy) | +650,000 | 650,000 | ||
| 2023-02-27 | Mowry Anna CFO and Treasurer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2023-02-27 | Murphy Matthew B. General Counsel | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2023-02-27 | Godwin Mary E. Senior VP, Operations | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2023-02-27 | Mallick Parag Chief Scientist | Grant or award · Stock Option (Right to Buy) | +280,000 | 280,000 | ||
| 2023-02-27 | Weld Gwen E Chief People Officer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2023-02-27 | Nelson Nicholas A. CBO & Senior VP, Bus. Dev. | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 |
Page 4 of 8 · 144 trades